XLPI Xcelplus International Inc (CE)

XcelPlus International Inc (Pink Sheets: XLPI), XcelPlus International (http://XcelPlus.com) announced today that it has sold the exclusive licensing rights for the distribution of the Eliminator 200 product in Canada. The licensing agreement is initially for a 5 year period and comes with a minimum purchase performance quota. The licensing agreement was signed with Prism Equity Holdings a Nevada Corporation with offices in Canada. When it comes to bird flu, Canada's poultry industry knows exactly what is at stake. An uncontrolled outbreak could cripple the $7-billion-a-year business from hatcheries, to farms, to processors, to supermarkets and restaurants. A Bird Flu outbreak in British Columbia's Fraser Valley in 2004 led to the slaughter of 17 million birds and cost it an estimated $340 million. A recent case in B.C. was found to have infected about 67,000 ducks. It is their intent to begin the distribution process of the product for Canada as a preventative measure to be used against the spread of the virus. Their immediate focus is to enter into a sub-licensing agreement with a major distributor that has 173 agents across Canada and in New York and New Jersey. They are committed to developing the Canadian markets with options to introduce the products to India, Europe, Central and South America on an exclusive basis. To further demonstrate that Eliminator 200 will establish the "new standard" for bio-hazard containment on surfaces of pens and other solid areas to eliminate the virus, it is being additionally tested in Australia. The lab in Australia utilizes state of the art technology in testing of bio-hazard containment and should yield results fairly quickly. The reason for further testing specifically in a state of the art facility in Australia is because this facility utilizes the British Standard that is the accepted test protocol for the ECU and is also accepted around the world. There is only one facility in the US equipped to do such testing which are back logged for months and do not have access to the H5N1 material for testing. Bill Smith, President of XcelPlus, states "this agreement and the further clinical testing of the Eliminator 200 product validation has enhanced the awareness and validity of this product. We look forward to the development of other business relationships and will inform our shareholders as these are established in the immediate future." Eliminator 200 formulation works on a bacterial, fungi or viral pathogen. Eliminator 200 works by oxidatively cleaving the amino and sulfur linkages in the protein chains that comprise the bacteria, viruses, fungi, etc., killing the organism with a powerful but selective oxidizing agent. Eliminator 200, which was tested in New Zealand, is listed as a sanitizer in the UK and New Zealand. Eliminator 200 has been approved by Agri-Quality NZ Ltd. up to food contact as a sanitizer.